Ross Muken
Stock Analyst at Evercore ISI Group
(3.38)
# 1,061
Out of 4,412 analysts
23
Total ratings
68.42%
Success rate
10.57%
Average return
Main Sectors:
Top Industries:
8 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON PLC | Maintains: Outperform | $350 → $330 | $304.14 | +8.50% | 3 | Apr 26, 2024 | |
| A Agilent Technologies | Maintains: In-Line | $132 → $145 | $139.59 | +3.88% | 8 | Apr 4, 2024 | |
| HSIC Henry Schein | Maintains: In-Line | $79 → $83 | $73.03 | +13.65% | 3 | Feb 28, 2024 | |
| CRL Charles River Laboratories International | Maintains: Outperform | $260 → $265 | $232.10 | +14.17% | 3 | Feb 15, 2024 | |
| CAH Cardinal Health | Initiates: In-Line | n/a | $102.91 | - | 2 | Jan 5, 2018 | |
| ILMN Illumina | Initiates: Outperform | n/a | $124.73 | - | 2 | Jan 4, 2018 | |
| QGEN Qiagen | Initiates: Outperform | $36 | $42.30 | -14.78% | 1 | Jan 4, 2018 | |
| TMO Thermo Fisher | Initiates: Outperform | n/a | $576.89 | - | 1 | Jan 4, 2018 |
ICON PLC
Apr 26, 2024
Maintains: Outperform
Price Target: $350 → $330
Current: $304.14
Upside: +8.50%
Agilent Technologies
Apr 4, 2024
Maintains: In-Line
Price Target: $132 → $145
Current: $139.59
Upside: +3.88%
Henry Schein
Feb 28, 2024
Maintains: In-Line
Price Target: $79 → $83
Current: $73.03
Upside: +13.65%
Charles River Laboratories International
Feb 15, 2024
Maintains: Outperform
Price Target: $260 → $265
Current: $232.10
Upside: +14.17%
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: n/a
Current: $102.91
Upside: -
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: n/a
Current: $124.73
Upside: -
Qiagen
Jan 4, 2018
Initiates: Outperform
Price Target: $36
Current: $42.30
Upside: -14.78%
Thermo Fisher
Jan 4, 2018
Initiates: Outperform
Price Target: n/a
Current: $576.89
Upside: -